Article | Published:

Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro

Nature Biotechnology volume 18, pages 399404 (2000) | Download Citation

Subjects

  • An Erratum to this article was published on 01 May 2000

Abstract

We describe the derivation of pluripotent embryonic stem (ES) cells from human blastocysts. Two diploid ES cell lines have been cultivated in vitro for extended periods while maintaining expression of markers characteristic of pluripotent primate cells. Human ES cells express the transcription factor Oct-4, essential for development of pluripotential cells in the mouse. When grafted into SCID mice, both lines give rise to teratomas containing derivatives of all three embryonic germ layers. Both cell lines differentiate in vitro into extraembryonic and somatic cell lineages. Neural progenitor cells may be isolated from differentiating ES cell cultures and induced to form mature neurons. Embryonic stem cells provide a model to study early human embryology, an investigational tool for discovery of novel growth factors and medicines, and a potential source of cells for use in transplantation therapy.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Establishment in culture of pluripotential stem cells from mouse embryos. Nature 292, 151–156 (1981).

  2. 2.

    Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci USA 78, 7634–7638 ( 1981).

  3. 3.

    et al Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Lab. Invest. 50, 147–162 (1984).

  4. 4.

    , , & Isolation and characterization of a multipotent clone of human embryonal carcinoma-cells . Differentiation 42, 10– 23 (1989).

  5. 5.

    et al. Cloned human teratoma cells differentiate into neuron-like cells and other cell types in retinoic acid. J. Cell Sci. 72, 37–64 (1984).

  6. 6.

    & Differentiation of pluripotent teratocarcinoma stem cells induced by bone morphogenetic protein-2. Reprod. Fertil. Devel. 10, 551–556 (1999).

  7. 7.

    et al. Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. USA 92, 7844– 7844 (1995).

  8. 8.

    et al. Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts. Biol. Reprod. 55, 254–259 (1996).

  9. 9.

    , , & Isolation and culture of inner cell mass cells from human blastocysts. Hum. Reprod. 9, 2110–2117 (1994).

  10. 10.

    et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 ( 1998).

  11. 11.

    et al. Comparative-analysis of cell-surface antigens expressed by cell-lines derived from human germ-cell tumors. Int. J. Cancer 66, 806–816 ( 1996).

  12. 12.

    , , & A novel keratan sulfate proteoglycan from a human embryonal carcinoma cell-line. Biochem. J. 286, 959–966 (1992).

  13. 13.

    et al. Analysis of cell-differentiation lineage in human teratomas using new monoclonal-antibodies to cytostructural antigens of embryonal carcinoma-cells . Differentiation 39, 139– 149 (1988).

  14. 14.

    , , & The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulphate proteoglycan . Cancer Res. 59, 4715– 4719 (1999).

  15. 15.

    et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379–391 (1998).

  16. 16.

    , , & Cultured cell lines from human germ cell tumours: windows into tumour growth and differentiation and early human development. Eur. Urol. 23, 82–88 (1993).

  17. 17.

    et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. USA 95, 13726–13731 (1998).

  18. 18.

    & Axis development and early asymmetry in mammals. Cell 96, 195–209 (1999).

  19. 19.

    et al. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein 7). Lab. Invest. 71, 243–251 (1994).

  20. 20.

    et al. In Inhibin, activin and follistatin: regulatory functions in system and cell biology (eds Aono, T., Sugino, H. & Vale, W.W.) 308–311 (Springer, New York, NY; 1997 ).

  21. 21.

    et al. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. Biotechnol. 16, 1033–1039 ( 1998).

  22. 22.

    et al. Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp. Neurol. 156, 333–344 ( 1999).

  23. 23.

    et al. Paracrine induction of stem cell renewal by LIF-deficient cells–a new ES cell regulatory pathway. Dev. Biol. 203, 149–162 (1998).

  24. 24.

    et al. Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors. J. Cell Sci. 112, 601–612 (1999).

  25. 25.

    et al. Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background. Nat. Genet. 14, 223– 226 (1996).

  26. 26.

    , , & Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr. Biol. 8, 971– 974 (1998).

  27. 27.

    & Comparison of human blastulation rates and total cell number in sequential culture media with and without co-culture . Hum. Reprod. 14, 774– 781 (1999).

  28. 28.

    et al. Ongoing pregnancy after transfer of zona-free blastocysts: implications for embryo transfer in the human. Hum. Reprod. 12, 557–560 (1997).

  29. 29.

    & Immunosurgery of mouse blastocyst . Proc. Natl. Acad. Sci. USA 72, 5099– 5102 (1975).

  30. 30.

    & Isolation and culture of primordial germ cells. Methods Enzymol. 225, 58– 76 (1993).

  31. 31.

    et al. Molecular cloning, genetic mapping, and developmental expression of bovine POU5F1. Biol. Reprod. 60, 1093 –1103 (1999).

  32. 32.

    et al. Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp. Neurol. 156, 71–83 (1999).

  33. 33.

    et al. GABAa receptor pharmacology and subtype expression in human neuronal NT2-N cells. J. Neurosci. 18, 4993–5007 (1998).

Download references

Acknowledgements

We gratefully acknowledge the assistance of Dr. Gary Dawson and the staff of the cytogenetics department, Monash Medical Centre, in the analysis of the karyotypes of the cell lines, and Mr. Peter Edwards of the biochemistry department, Monash Medical Centre, for immunoassay of human chorionic gonadotrophin and α-fetoprotein. Tianhao Xiang assisted with the RT-PCR assay for Oct-4. We thank Ms. Jacqui Johnson for assistance with cell culture.

Author information

Affiliations

  1. Monash Institute of Reproduction & Development, Monash University, Melbourne, Victoria, Australia

    • Benjamin E. Reubinoff
    • , Martin F. Pera
    •  & Alan Trounson
  2. Department of Obstetrics & Gynaecology, Hadassah University Hospital, Ein-Karem, Jerusalem, Israel

    • Benjamin E. Reubinoff
  3. Department of Obstetrics & Gynaecology, National University of Singapore, Singapore

    • Chui-Yee Fong
    •  & Ariff Bongso

Authors

  1. Search for Benjamin E. Reubinoff in:

  2. Search for Martin F. Pera in:

  3. Search for Chui-Yee Fong in:

  4. Search for Alan Trounson in:

  5. Search for Ariff Bongso in:

Corresponding author

Correspondence to Martin F. Pera.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/74447

Further reading